Travere Therapeutics 주식 (NASDAQ: TVTX)

에 대한 최신 뉴스 Travere Therapeutics (NASDAQ:TVTX) 주식

Travere Therapeutics

Travere Therapeutics Inc is a biopharmaceutical company. The company is focused on identifying, developing and delivering life-changing therapies to people living with rare kidney, liver, and metabolic diseases. Its pipeline candidate, sparsentan, is an investigational product candidate in late-stage development for focal segmental glomerulosclerosis (FSGS) and IgA nephropathy (IgAN) - rare kidney disorders that often cause end-stage kidney disease.

Earnings

News

Pre-Market Outlook

Markets

Trading Ideas

COST

MITQ

NVNO

SCHL

TVTX

금요일 오전 (현지 시간 기준) 미국 주식 선물 거래가 혼조세를 보이고 있는 가운데 오늘 투자자들의 관심을 끌 수 있는 주식은 다음과 같다: 1. 코스트코 홀세일(NASDAQ:COST)는 4분기 긍정적인 실적을 발표했지만, 매출은 예상에 미치지 못했다. 이 회사는 분기 매출이 796.97억 달러로, 컨센서스 추정치인 799.73억 달러를 밑돌았다고 보고했다. 이 회원제 소매업체는 분기당 주당 순이익이 5.29달러로, 애널리스트 추정치인 5.08달러를 초과했다고 보고했다. 코스트코의 주식은 시간외 거래에서 1.4% 하락한 888.62달러에 거래되었다.

금요일 주목해야 할 주식: 코스트코, 스콜라스틱, 무빙 이미지 그리고 2종목

Travere Therapeutics, Inc. - Common Stock

Travere Therapeutics Inc

The Brazilian mining giant Vale SA (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VALE#NYSE">VALE</a>) announced its commitment to significantly boost <a href="https://www.benzinga.com/topic/copper">copper</a> production under its new CEO, Gustavo Pimenta.
Pimenta, a former CFO who became CEO after a <a href="https://www.benzinga.com/news/24/08/40597248/vale-selects-cfo-gustavo-pimenta-as-new-ceo-ending-turbulent-succession-process">turbulent succession process</a>, spoke to the media for the first time in his new role. He <a href="https://www.bloomberg.com/news/articles/2024-10-02/vale-backs-brazil-critical-minerals-fund-in-nod-to-government">acknowledged</a> that Vale has "fallen behind on copper " compared to industry peers but plans to close that gap, Bloomberg reported.
This year, Vale expects to produce between 320,000 and 355,000 metric tons of copper — well below the output of its size-related industry peers. Pimenta plans to raise the output of its assets in Brazil, Canada and Indonesia to around 500,000 tons before considering other options.
In addition to growing copper production, Vale focuses on investments in strategic minerals essential for the global energy transition. The firm has been under pressure from the Brazilian government, which pleaded for increased domestic investments.
In collaboration with Brazil's development bank, BNDES, Vale will invest around $184 million in junior and mid-sized companies working on minerals like nickel and cobalt — crucial for electric vehicles and renewable energy technologies.
Despite these ambitions, Vale faces several challenges. As the largest iron ore producer globally, the firm has experienced a slowdown in China's economy, a critical market for that commodity. Additionally, the aftermath of the catastrophic 2015 dam collapse still requires <a href="https://www.benzinga.com/markets/equities/24/01/36799749/brazilian-judge-slams-mining-giants-vale-and-bhp-with-9-67b-charges-over-dam-collapse-report">substantial financial and legal settlements</a>, creating a drain on the firm's resources.
However, Vale's rapidly evolving copper market peers are not sitting idle. Barrick has been ramping production and <a href="https://www.benzinga.com/news/24/09/40851842/barrick-to-complete-feasibility-study-for-lumwana-mine-expansion-start-construction-in-2025">investing $2 billion </a>in expansion at its Lumwana mine in Zambia, which is set to double copper output to 240,000 tons per year by 2028. Barrick is also advancing its Reko Diq project in Pakistan, further boosting its copper and gold production.
Meanwhile, Australian miner BHP has identified copper as a <a href="https://www.benzinga.com/news/large-cap/24/10/41114374/bhp-sees-trend-reversal-in-copper-growth-warns-recycling-wont-be-enough">key growth pillar</a>, anticipating a 70% increase in global demand by 2050. BHP is expanding its copper portfolio, focusing on existing operations and potential new projects like Oak Dam in Australia, addressing aging mines and declining ore grades.
With copper touted as a cornerstone metal for the green tech transition, Vale's new management has a lot of ground to cover before catching up to its competitors which are committed to multi-billion-dollar projects.
Read Next: • <a href="https://www.benzinga.com/government/24/10/41172781/oil-prices-rally-biden-confirms-us-discussions-with-israel-about-striking-iran-facilities">Oil Prices Rally: Biden Confirms US &#8216;Discussions&#8217; With Israel About Striking Iran Facilities</a>
Photo: Shutterstock

Large Cap

Commodities

Global

VALE

Vale Plans To Expand Copper Output, Invests $184M For Domestic Critical Minerals

BIC is making headlines again with the launch of the limited-edition &#8220;Hold the Phone&#8221; Case by BIC EZ Reach Lighters.
The company announced its multi-year partners &#8211; Snoop Dogg and Martha Stewart – are an inspiration for the two phone cases matching the celebrity duo&#8217;s iconic signature BIC EZ Reach Lighter designs.
Jeany Mui, marketing director at BIC Flame for Life, said the &#8216;Hold the Phone&#8217; Cases by BIC EZ Reach Lighters celebrate the collaboration with Stewart and Snoop.
&#8220;Building on the success of our previous campaigns and the legendary pair&#8217;s undeniable chemistry, we&#8217;re thrilled to launch another must-have accessory ahead of the holiday season,&#8221; Mui said.
<figure class="wp-block-image size-full"><a href="https://www.benzinga.com/events/cannabis-conference/"><img loading="lazy" decoding="async" width="970" height="250" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/10/03165146/ccc-oct-24-banner__1_-7.gif" alt="" class="wp-image-579538" /></a></figure>
BIC previously reintroduced its EZ Reach Lighters&#8217; &#8220;Most Borrowed&#8221; campaign in early 2014, featuring <a href="http://benzinga.com/topic/willie-nelson" target="_blank" rel="noreferrer noopener">Willie Nelson</a>, <a href="http://benzinga.com/topic/Snoop-Dogg" target="_blank" rel="noreferrer noopener">Snoop Dogg</a> and <a href="http://benzinga.com/topic/martha-stewart" target="_blank" rel="noreferrer noopener">Martha Stewart</a>. The campaign has driven remarkable consumer sentiment and a notable increase in <a href="https://www.benzinga.com/markets/cannabis/24/01/36616705/snoop-dogg-willie-nelson-and-martha-stewart-team-up-in-new-bic-lighters-ad-bic-executive-explain">year-over-year sales since its inception.</a>
The illustrious trio teamed up this past April yet again to promote its EZ Reach lighter and to celebrate the 4/20 cannabis holiday.
<ul>
<li>Get Benzinga's exclusive analysis and the top news about the cannabis industry and markets daily in your inbox for free. Subscribe to our newsletter <a href="https://newsletteremail.benzinga.com/subscribe" target="_blank" rel="noreferrer noopener">here</a>. If you're serious about the business, you can't afford to miss out.</li>
</ul>
Launched at 4:20 pm on 4/20, the event, titled the "Slow Burn Sessions," featured the trio for 4 hours and 20 minutes of exclusive content on <a href="https://www.youtube.com/@bicbrand">Bic's YouTube channel</a> all weekend, giving viewers a chance to unwind with three mood-setting segments, representing each <a href="https://www.benzinga.com/markets/cannabis/24/04/38346359/snoop-dogg-willie-nelson-and-martha-stewart-light-up-on-420-with-bics-slow-burn-sessions-heres-h">celeb and with its own flare.</a>
Read Also: <a href="https://www.benzinga.com/markets/cannabis/23/04/31911647/exclusive-where-is-snoop-doggs-ez-reach-lighter-bic-lights-up-america-to-find-out-in-a-420-campa">Exclusive: Where Is Snoop Dogg&#8217;s EZ Reach Lighter? BIC Lights Up America To Find Out In A 4/20 Campaign Featuring Willie Nelson And Martha Stewart</a>
Stewart said in the press release she's keeping BIC EZ Reach Lighter designs close. "I keep one of my own BIC EZ Reach Lighter designs in nearly every room of my home, and with the launch of our &#8216;Hold the Phone&#8217; by Case by BIC EZ Reach Lighters, I can easily bring my favorite lighters with me on-the-go."
<h3 class="wp-block-heading">Where To Find The New Accessory?</h3>
As of Friday, Oct. 4, consumers can exclusively head to BIC&#8217;s website to purchase the limited-edition iPhone 15-compatible Martha Stewart or Snoop Dogg-themed &#8220;Hold the Phone&#8221; Cases by BIC EZ Reach Lighters.
Each case &#8211; priced at $49.99 &#8211; includes two BIC EZ Reach Lighters based on the case design selected.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/markets/cannabis/24/07/40047948/snoop-dogg-rolls-out-first-cannabis-coffeeshop-in-amsterdam-its-only-right-that-i-bring-s-w-e-d-">Snoop Dogg Rolls Out First Cannabis Coffeeshop In Amsterdam: &#8216;It&#8217;s Only Right That I Bring S.W.E.D. Global To This Iconic City&#8217;</a></li>
</ul>
<ul>
<li><a href="https://www.benzinga.com/markets/cannabis/23/11/36002268/martha-stewart-and-canopy-growth-launch-new-cbd-gummies-just-in-time-for-the-holidays">Martha Stewart And Canopy Growth Launch New CBD Gummies Just In Time For The Holidays</a></li>
</ul>

Cannabis

Entertainment

Entrepreneurship

Retail Sales

BIC Rolls Out Snoop Dogg And Martha Stewart-Inspired Limited-Edition Accessory, Here's Where To Find It

Social media company Meta Platforms Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/META#NASDAQ">META</a>) has paid out over $2 billion to content creators this year as it works to boost monetization efforts for <a href="https://www.benzinga.com/news/24/04/38085248/instagram-creators-can-now-earn-upto-30k-in-a-month-with-reels-photo-carousels-and-more-as-meta-revi">users of the platform.</a>
Here's a look at what the company has done and what's next.
 What Happened: Meta Platforms&#8217; Facebook began monetization efforts in 2017 because it wanted to compete with other social media platforms and<a href="https://www.benzinga.com/topic/youtube"> video outlets such as YouTube.</a>
The company has paid out $2 billion over the last year with payouts for short-form videos and Reels up 80% year-over-year, as <a href="https://techcrunch.com/2024/10/02/facebook-says-it-paid-content-creators-2b-this-year/">reported </a>by TechCrunch.
Facebook said that more than four million content creators have earned money from the platform since 2017.
While the $2 billion figure is large and could be eye-catching to lure content creators to Facebook, the figure is a fraction of the $70 billion paid out by YouTube to content creators over the last three years as part of its partner program, TechCrunch reported.
Did You Know?
<ul>
<li>Congress Is Making Huge Investments. <a href="https://www.benzinga.com/gov-trades/?utm_source=BZprocontent100324">Get Tips On What They Bought And Sold Ahead Of The 2024 Election With Our Easy-to-Use Tool</a></li>
</ul>
 What's Next: To help grow its content creation, Meta announced several changes this week.
The company is <a href="https://about.fb.com/news/2024/10/monetize-content-facebooks-new-streamlined-program/">rolling </a>out Facebook Content Monetization, which combines three existing creator monetization efforts (in-stream ads, ads on Reels, Performance bonus) into one platform.
Creators on the new platform can earn from photos, text posts, short videos and longer videos, according to the company.
"We're proud of how our monetization programs have helped creators thrive on Facebook, but we know that the different availability, eligibility requirements and sign-up processes of our various programs have resulted in some creators missing opportunities and other not being eligible to earn from all available formats," the company said.
With the new platform, creators only have to join one platform with several ways to monetize their content.
The company sent out invitations to one million creators as part of the content monetization beta launch. Additional invitations will be sent in the "following months."
Open enrollment for the content monetization platform begins in 2025.
META Price Action: Meta stock closed Monday up 1.74% to $582.77 on Thursday versus a 52-week trading range of $279.40 to $583.36. Meta stock is up 68.3% year-to-date in 2024.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/top-stories/24/10/41150827/exclusive-top-20-most-searched-tickers-on-benzinga-pro-in-september-2024-where-do-tesla-nvidia-apple">EXCLUSIVE: Top 20 Most-Searched Tickers On Benzinga Pro In September 2024 – Where Do Tesla, Nvidia, Apple, DJT Stock Rank?</a></li>
</ul>
Photo: Shutterstock

Social Media

Tech

Mark Zuckerberg's Facebook Paid $2B To Content Creators In The Past Year — And It Wants To Pay Out More

Afrimat (OTC:<a class="ticker" href="https://www.benzinga.com/stock/AFTLF#OTC">AFTLF</a>) is known for its operations in lime, iron ore, anthracite and manganese, has made a move into the hemp industry by partnering with legacy brand Hemporium.
Together, they are using hemp-based materials to expand a building in Cape Town. This venture raises questions: is Afrimat betting on the future of South Africa&#8217;s hemp industry, or is it a PR stunt?
The investment comes at a time when South Africa is pushing to grow the sector, having recently issued 1,110 permits for hemp cultivation as part of the government&#8217;s <a href="https://www.benzinga.com/markets/cannabis/24/09/40887359/south-africa-issues-1-110-hemp-licenses-is-the-industry-leaving-small-farmers-behind">master plan</a> under the Cannabis for Private Purposes Bill.
Afrimat's involvement could provide the industry with <a href="https://www.benzinga.com/markets/cannabis/24/07/39824908/south-african-companies-prepare-for-new-cannabis-regulations-experts-expect-lots-of-fundraising-">much-needed capital to scale</a>.
<ul>
<li>Get Benzinga's exclusive analysis and the top news about the cannabis industry and markets daily in your inbox for free. Subscribe to our newsletter&nbsp;<a href="https://newsletteremail.benzinga.com/subscribe" target="_blank" rel="noreferrer noopener">here</a>. You can&#8217;t afford to miss out if you're serious about the business.</li>
</ul>
<h3 class="wp-block-heading">Afrimat's Green Transition</h3>
Afrimat's collaboration with Hemporium signals the company's interest in sustainability.&nbsp;
Beyond its mining operations, the publicly-traded Afrimat has been working on renewable energy initiatives, recycling mining by-products and rehabilitating mined-out areas through reforestation and water conservation projects, <a href="https://hemptoday.net/what-is-a-mining-conglomerate-like-south-africas-afrimat-doing-in-industrial-hemp/">reported</a> Hemp Today. 
Mining operations for materials like lime, iron ore, anthracite and manganese have significant environmental impacts. Iron ore mining, for example, can <a href="https://link.springer.com/article/10.1007/s11270-024-07048-x">contaminate water sources </a>through increased sediment levels and metal runoff, while the removal of vegetation for mining operations drastically reduces biodiversity. <a href="https://link.springer.com/chapter/10.1007/978-3-030-38152-3_8">Limestone mining </a>similarly contributes to environmental degradation by altering land-use patterns and causing dust and noise pollution, which can harm local ecosystems and communities. 
Read Also:&nbsp;<a href="https://www.benzinga.com/general/biotech/24/07/39894649/the-wall-that-can-withstand-1700-f-and-cut-10b-in-losses-fire-resistant-hempcrete-now-certified">The Wall That Can Withstand 1700°F And Cut $10B In Losses: Fire-Resistant Hempcrete Now Certified</a>
<h3 class="wp-block-heading">Hemp Town</h3>
The hemp-lime block technology used in Cape Town, combined with specialized binders, promises to offer a sustainable alternative in the construction industry.&nbsp;
Hemporium and <a href="https://www.afrimathemp.co.za/">Afrimat Hemp</a>, a subsidiary of Afrimat, are nearing the completion of a seven-story expansion on an existing five-story building. The new structure, built with 28 cm-thick hemp blocks, will bring the building's total height to 12 stories.&nbsp;
The space will house Hemporium's flagship retail outlet, where they will sell<a href="https://www.benzinga.com/topic/hemp"> hemp-derived</a> clothing, skincare and CBD products, along with a steak restaurant and 50 hotel rooms.
The walls are built with <a href="https://www.benzinga.com/general/biotech/24/02/37271000/u-s-army-invests-1-9m-to-develop-hemp-manufactured-buildings-for-military-operations">hempcrete blocks</a>, made by Afrimat Hemp from European hemp hurd and locally sourced lime, capable of withstanding fire for 135 minutes.
The building also features solar panels, smart metering, a borehole with filtration for backup water and a thermally activated building system (TABS) to regulate temperature without mechanical heating or cooling.
Read Also: <a href="https://www.benzinga.com/markets/cannabis/24/09/40756333/gov-newsom-proposes-emergency-rules-to-severely-restrict-hemp-products-this-will-destroy-our-bus">Gov. Newsom&#8217;s Total Ban On Hemp THC Could Crush California&#8217;s Billion-Dollar Industry, Say Stakeholders (UPDATED)</a>
<h3 class="wp-block-heading">How Is Concrete Made Out Of Hemp? </h3>
Hempcrete, a <a href="https://www.benzinga.com/markets/cannabis/24/07/40027836/hempcrete-project-gets-6-2m-epa-grant-to-develop-eco-friendly-construction-materials">sustainable building material</a>, begins with harvesting the stalks of the hemp plant. Once harvested, the stalks are left on the ground for 10 to 14 days to degrade the outer fibers. This microbial breakdown helps release the inner woody core, known as the hemp hurd, which is the essential construction material.
After this process, the <a href="https://www.benzinga.com/topic/hemp">hemp</a> stalks are collected, crushed and sorted to separate the fiber from the hurd. The hurd, chopped into small particles (typically around 1 inch), is cleaned to remove dust, ensuring the quality of the material.
The next step involves mixing the processed hemp hurd with lime and water. The typical ratio is three parts hemp, one part lime, and one part water, although these proportions can vary depending on the humidity and specific requirements of the project. This mixture is then used to create blocks or panels for construction.
In some cases, the mixture is poured into molds to make bricks, which are compacted and allowed to air dry or placed in an oven. Alternatively, for larger structures, the mixture can be poured directly into formwork to create whole walls, reducing the need for individual brick assembly.
Hempcrete is known for being lightweight &#8211; 50% lighter than traditional concrete &#8211; and ten times more insulating, offering an eco-friendly and flexible building solution. 
Read Next:&nbsp;<a href="https://www.benzinga.com/markets/cannabis/22/02/25762696/is-hempcrete-the-new-green-construction-material-it-could-soon-be-approved-as-just-that">Is Hempcrete The New Green Construction Material? It Could Soon Be Approved As Just That</a>

Biotech

Market Summary

Emerging Markets

Contracts

Success Stories

General

AFTLF

Publicly Traded South African Mining Co. Invests In Fire-Resistant Hemp Buildings - New Industry Or PR Stunt?

The upfront cash payment brings non-dilutive capital to Editas Medicine, helping enable further pipeline development and related strategic priorities.
Under the terms of the agreement, Editas Medicine will receive an upfront cash payment of&nbsp;$57 million&nbsp;in exchange for up to&nbsp;100%&nbsp;of certain future annual license fees payable to Editas Medicine, ranging from&nbsp;$5 million&nbsp;to&nbsp;$40 million&nbsp;per year (inclusive of certain sales-based annual license fees that may become due) and a mid-double-digit percentage of Editas Medicine&#39;s portion of a&nbsp;$50 million&nbsp;contingent upfront payment for which Editas Medicine is eligible under the Vertex license agreement.
In addition to a portion of any such contingent upfront payment, Editas Medicine retains rights to fixed annual license fees for 2024 and a mid-single-digit million-dollar payment due to Editas Medicine in the event of Vertex&#39;s achievement of certain annual sales milestones.

Asset Sales

EDIT

Editas Medicine Reports Sale Of Certain Future License Fees, Other Payments Owed Under Cas9 License Agreement With Vertex To DRI Healthcare Trust Subsidiary For Upfront Cash Payment Of $57M

LGIH

LGI Homes Says It Closed 579 Homes In September, Up 7.2% Y/Y, Resulting In Total Of 1,757 Homes Closed During Q3

The deal includes an exclusive license to manufacture, upgrade, and repair the product line. The agreement also grants IS&amp;S exclusive intellectual property rights and includes the transfer of existing inventory necessary for continued manufacturing and support of the products.
This acquisition significantly expands IS&amp;S&#39;s capabilities and enhances its presence within the military aviation sector. Following a transition period, IS&amp;S, will be responsible for the activities formerly performed by Honeywell.

ISSC

Innovative Solutions & Support Buys License For Various Generations Of Military Display Generators And Flight Control Computers From Honeywell; No Terms Disclosed

For the three months ended September 30, 2024, the Company had an average of 107 drilling rigs operating in the United States.

PTEN

Patterson-UTI Reports Average Of 107 Drilling Rigs Operating In US For September

Despite achieving <a href="https://www.benzinga.com/markets/cannabis/24/04/38076225/another-record-breaking-month-for-new-mexicos-cannabis-industry-heres-how-much-retailers-garnere">over $1 billion in sales</a> since the legalization of recreational cannabis 29 months ago, New Mexico&#8217;s cannabis industry is grappling with severe regulatory challenges. A year-long <a href="https://www.krqe.com/news/larry-barker/the-new-mexico-cannabis-cowboys-modern-day-desperados/">investigation</a> by KRQE&#8217;s Larry Baker has uncovered serious regulatory issues in <a href="https://www.benzinga.com/topic/new-mexico-cannabis">New Mexico's cannabis industry</a>, which has attracted lawbreakers and crime networks.&nbsp;
<h2 class="wp-block-heading">Lack Of Regulatory Oversight</h2>
According to the report, the Cannabis Control Division (CCD) is under-resourced, with only nine inspectors overseeing 3,000 licensed cannabis businesses. This understaffing has led to a situation where many operations go uninspected, allowing criminal enterprises, some linked to international criminal networks in Mexico and <a href="https://www.benzinga.com/markets/cannabis/24/06/39559399/new-mexicos-dark-discovery-chinese-workers-trapped-on-illegal-cannabis-farms">China</a>, to thrive without scrutiny. This loophole could be the result of the state&#8217;s licensing process.
In a podcast <a href="https://www.krqe.com/podcasts/the-growing-black-market-inside-new-mexicos-cannabis-industry/">interview</a> with KRQE, Duke Rodriguez, CEO of Ultra Health, New Mexico's largest cannabis operator, highlighted the gravity of the situation, revealing that two-thirds of the state's cannabis activity remains illicit. He criticized the state&#8217;s licensing system, describing it as an ineffective &#8220;honor system,&#8221; where applicants are granted licenses with the assumption they won&#8217;t violate regulations.
Rodriguez explained that inspections occur only after the license is issued and the business is already operational. The state can only intervene if irregularities are found during these inspections. "You won't see that anywhere else in the country," added Larry Barker, noting that enforcement delays often mean businesses can operate for 12 to 18 months without proper oversight.
<h3 class="wp-block-heading">Change In The State&#8217;s Regulatory Approach</h3>
Rodriguez also pointed out that under the old <a href="https://www.benzinga.com/markets/cannabis/22/04/26481542/new-mexico-legal-cannabis-program-up-and-running-raking-in-millions">medical cannabis program</a>, such infractions would have led to immediate license suspension or revocation. However, since <a href="https://www.benzinga.com/markets/cannabis/21/04/20589377/adult-use-cannabis-is-now-legal-in-new-mexico-gov-signs-legalization-expungement-bills">recreational cannabis legalization</a>, the lack of enforcement has allowed illegal operations to flourish unchecked. &#8220;The lack of enforcement is hurting the state&#8217;s economy,&#8221; he said, adding that the regulated market struggles to compete with its illicit counterpart.
"The state simply took its hands off the steering wheel … just issue a license to anyone who marked the boxes. And that's what they did," Rodriguez said. He added that while Governor Michelle Lujan Grisham celebrated the state surpassing $1 billion in legal cannabis sales in March 2024, most of the sales figures were tied to political optics rather than a reflection of a healthy market.The CCD's limited ability to collect fines or shut down rogue operations further complicates the situation.
<h3 class="wp-block-heading">Systemic Lack Of Enforcement</h3>
Barker's investigation found that only about 10% of cannabis businesses consistently comply with reporting regulations. Even when the CCD takes action, it struggles to enforce penalties. Barker cited one <a href="https://www.benzinga.com/markets/cannabis/24/01/36473694/new-mexico-clamps-down-2m-fines-for-cannabis-farm-violations">cannabis farm fined $1 million</a> for rule violations, but it remains unpaid and the farm is still operational. "They have the authority to issue fines but not to collect them," Barker explained, highlighting the regulatory division's limited power.
Rodriguez echoed these concerns, saying that the state's lack of enforcement has fostered a rampant illicit market. "We're just creating this overly illegal, illicit black market," he said, noting that the number of rogue operations likely extends beyond what has been uncovered.
Cover image made with AI

Regulations

New Mexico's Cannabis Industry Struggles Against Criminal Exploitation And Regulatory Failures

Bristol Myers Squibb Says FDA Approved Perioperative Treatment Of Neoadjuvant Opdivo (Nivolumab) And Chemotherapy Followed By Surgery And Adjuvant Single-Agent Opdivo For Resectable Non-Small Cell Lung Cancer

Vistra Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VST#NYSE">VST</a>) and Constellation Energy Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CEG#NASDAQ">CEG</a>) shares traded higher Thursday after RBC Capital raised price targets on both stocks amid growing demand for energy to power data centers and<a href="https://www.benzinga.com/news/24/09/41032700/whats-going-on-with-vistra-stock"> other AI infrastructure. </a>
The Details: Energy stocks continue to climb as demand for electricity to power data centers and other AI applications soars. Alphabet Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOOG#NASDAQ">GOOG</a>) (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOOGL#NASDAQ">GOOGL</a>) CEO Sundar Pichai told Nikkei in <a href="https://asia.nikkei.com/Editor-s-Picks/Interview/Google-considers-sourcing-from-nuclear-power-plants-says-CEO-Pichai">an interview </a>on Thursday that Google is considering powering its data centers with nuclear power plants. 
Constellation Energy already signed a 20-year nuclear power<a href="https://www.benzinga.com/markets/equities/24/09/40957437/microsoft-taps-constellation-for-20-year-carbon-free-power-3-400-jobs-coming-to-pennsylvania"> purchase agreement</a> with Microsoft Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MSFT#NASDAQ">MSFT</a>) to deliver clean energy to its AI infrastructure. The comments from Google's CEO suggest other AI hyper-scalers may follow the same path. 
Read Next: <a href="https://www.benzinga.com/news/24/10/41152629/what-happened-with-accenture-stock-today">What Happened With Accenture Stock Today?</a>
RBC Capital analyst Shelby Tucker maintained Vistra with an Outperform and raised the price target on the stock from $105 to $141. The RBC analyst also maintained a Sector Perform rating on Constellation Energy and raised its price target from $214 to $272 on Thursday.
Vistra was the best performer in the S&amp;P 500 Index on Thursday and remains the best performer in the S&amp;P 500 year-to-date. According to data from <a href="https://pro.benzinga.com/?gspk=YWRhbWVja2VydDUzMzY&amp;gsxid=zBMR4PKmcgBw">Benzinga Pro</a>, Vistra has jumped 243% in 2024 and Constellation Energy is up 137% year-to-date.&nbsp;
VST, CEG Price Action: According to <a href="https://pro.benzinga.com/?gspk=YWRhbWVja2VydDUzMzY&amp;gsxid=zBMR4PKmcgBw">Benzinga Pro</a>, Vistra shares ended Thursday's session up 5.65% at $132.45 and Constellation Energy shares closed up 4.52% at $277.37.
Read Also:
<ul>
<li><a href="https://www.benzinga.com/markets/cryptocurrency/24/10/41122476/whats-going-on-with-microstrategy-stock">What&#8217;s Going On With MicroStrategy Stock?</a></li>
</ul>
Photo: Shutterstock

Analyst Color

Analyst Ratings

Movers

GOOG

GOOGL

MSFT

What Happened With Vistra, Constellation Energy Stocks Today?

Cannabis consumption provides medicinal benefits, even when deemed recreational. Whether for pain, stress, anxiety or sleep, consumers' motivations often overlap across both categories.
Recent research from<a href="https://newfrontierdata.com/"> New Frontier Data </a>looks at how these motivations blur traditional distinctions between medical and recreational marijuana use, challenging perceptions about their differences.
As the cannabis industry grows, this overlap becomes even more significant. Investors who understand these shifting behaviors and evolving legal frameworks in each state will be best positioned to capitalize on the next wave of growth opportunities.
<ul>
<li>Get Benzinga's exclusive analysis and the top news about the cannabis industry and markets daily in your inbox for free. Subscribe to our newsletter&nbsp;<a href="https://newsletteremail.benzinga.com/subscribe" target="_blank" rel="noreferrer noopener">here</a>. You can&#8217;t afford to miss out if you're serious about the business.</li>
</ul>
<h3 class="wp-block-heading">New Frontiers For Cannabis&nbsp;</h3>
The study surveyed 3,868 U.S. cannabis consumers, asking them to classify their use as medical, recreational, or both. It analyzed consumption patterns, demographics, and spending habits, offering key insights into what drives different types of users.&nbsp;
This data sheds light on consumer behavior and its impact on market trends.
States like <a href="https://www.benzinga.com/topic/ohio-cannabis">Ohio</a> have already transitioned to recreational cannabis, while <a href="https://www.benzinga.com/topic/florida-cannabis">Florida</a>, is poised for legalization in 2024 if a ballot initiative is approved. <a href="https://www.benzinga.com/topic/arkansas-cannabis">Arkansas</a>, <a href="https://www.benzinga.com/topic/nebraska-cannabis">Nebraska</a>, <a href="https://www.benzinga.com/topic/south-dakota-cannabis">South Dakota</a>, and <a href="https://www.benzinga.com/markets/cannabis/24/07/39602457/majority-of-north-dakotans-are-against-legal-weed-new-poll-finds">North Dakota</a> are also advancing ballot initiatives. <a href="https://www.benzinga.com/topic/pennsylvania-cannabis">Pennsylvania</a> and <a href="https://www.benzinga.com/topic/wisconsin-cannabis">Wisconsin</a> are pushing forward despite political challenges.
<h3 class="wp-block-heading">Gender Differences And Consumer Behavior</h3>
According to the survey, women make up 46% of the cannabis consumer base and are more likely than men to use cannabis solely for medical purposes. However, both genders report similar rates of recreational use. 
Additionally, home growers, though representing a minority at 54% of non-growers, are significantly more likely to use cannabis for both medical and recreational purposes​. 
"Market type is significantly correlated with <a href="https://www.benzinga.com/markets/cannabis/24/05/38972587/who-is-buying-marijuana-and-why-market-data-provides-behavior-profiles-insights-for-investors">self-identified consumer type</a>. It is interesting to note that, even in medical-only markets, 27% of consumers consider themselves recreational only," reads the report.&nbsp;
<h3 class="wp-block-heading">Who Spends The Most? </h3>
Medical-only consumers exhibit higher<a href="https://www.benzinga.com/markets/cannabis/24/06/39540101/budget-conscious-consumers-boost-sales-of-marijuana-multipacks-94-brands-vie-for-colorados-pre-r"> spending habits</a>, with many spending over $400 per purchase. By contrast, recreational consumers typically spend under $50, with some even obtaining cannabis for free. This discrepancy highlights the deeper financial commitment of those using cannabis for medical reasons, often tied to long-term therapeutic needs.
Read Also: <a href="https://www.benzinga.com/markets/cannabis/24/08/40533363/how-seo-trauma-is-costing-weed-brands-70-of-sales-and-why-most-dispensaries-fail-jp-donahue-unle">How SEO Trauma Is Costing Weed Brands 70% Of Sales —And Why Most Dispensaries Fail: JP Donahue Unleashed</a>
<h3 class="wp-block-heading">How Often?&nbsp;</h3>
Those who use cannabis for both medical and recreational purposes consume more frequently, often <a href="https://www.benzinga.com/markets/cannabis/24/02/37221610/how-many-joints-a-day-are-safe-researchers-identify-methods-for-weed-consumption-within-healthy-">multiple times per day</a>, while recreational-only users tend to consume the least. The report found that medical users are far more likely to report positive impacts on their lives from cannabis use, whereas recreational users often cite a mixed effect.
<h3 class="wp-block-heading">Market Loyalty</h3>
Medical users also show greater loyalty to specific businesses, purchasing from the same source for product consistency and reliability. In contrast, recreational users are less likely to stick with one store, leaning toward more varied buying habits. 
This difference underscores the need for reliable, consistent products in medical marijuana markets.
&#8220;Medical-only consumers were the most likely to say that they always source their <a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/03/37666783/marijuana-shoppers-favorite-strains-2024">cannabis from the same business</a>, while recreational-only consumers were the most likely to say they buy from different stores. This reflects the need of medical consumers to have consistent access to the same products,&#8221; reads the report.
Read Next: <a href="https://www.benzinga.com/markets/cannabis/24/10/41154738/ohio-cannabis-market-soars-to-76m-in-less-than-2-months-but-michigan-remains-the-leader">Ohio Cannabis Market Soars To $76M In Less Than 2 Months But Michigan Remains The Leader</a>

Guidance

Management

What's The Difference Between Medical And Recreational Cannabis Users? New Survey Reveals Market Trends

Vizimax is a provider of innovative solutions to measure, control and switch high- and medium-voltage electric power systems.
Headquartered in Longueuil, Quebec, Vizimax is led by President Jean-Guy Lacombe and was previously owned by a group of investors led by BDC Capital and Yaletown Ventures.
&nbsp;

Blackstone Portfolio Company Power Grid Components Acquires Vizimax; No Terms Disclosed

IonQ Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IONQ#NYSE">IONQ</a>) shares are bouncing around in Thursday&#8217;s after-hours session after the company announced it reached a significant milestone in developing networked <a href="https://www.benzinga.com/pressreleases/24/10/b41173403/ionq-demonstrates-remote-ion-ion-entanglement-a-significant-milestone-in-developing-networked-quan">quantum systems at scale</a>.
What Happened: After the market close on Thursday, IonQ said it successfully demonstrated remote ion-ion entanglement, crossing off another milestone of its scaling strategy.
IonQ announced it achieved ion-photon entanglement in February. The remote ion-ion entanglement marks the second of four significant milestones required to develop photonic interconnects and take a foundational step towards quantum networking.
&#8220;IonQ&#8217;s north star remains scalability at high performance, and the progress we&#8217;ve made towards photonic interconnects ensures our customers will have access to large quantum systems capable of tackling the most complex problems,&#8221; said Peter Chapman, president and CEO of IonQ.
&#8220;We&#8217;re consistently making significant headway on our technical roadmap, and customers across academia and business recognize the unique value IonQ&#8217;s systems bring as we near the point of commercial quantum advantage.&#8221;
Check This Out: <a href="https://www.benzinga.com/markets/cryptocurrency/24/09/41037763/kamala-harris-strengthens-crypto-stance-the-us-will-remain-dominant-in-ai-and-quantum-comp">Kamala Harris Strengthens Crypto Stance: The US Will &#8216;Remain Dominant In AI And Quantum Computing, Blockchain, And Other Emerging Technologies&#8217;</a>
The news comes less than a week after the company <a href="https://www.benzinga.com/markets/equities/24/09/41071006/why-is-ionq-stock-trading-higher-on-friday">announced</a> that it signed a $54.5 million contract with the U.S. Air Force Research Lab and said it remains on track to nearly double its revenue for the third year in a row. IonQ shares are up about 15% since the announcement. 
IonQ is scheduled to <a href="https://x.com/IonQ_Inc/status/1840843273352679778">host a session</a> with data software company Evidentli on Oct. 11. The session will focus on the transformational potential quantum computing offers to the pharmaceutical industry. 
According to the <a href="https://www.eventbrite.com.au/e/generative-ai-20-for-data-harmonisation-and-federated-analytics-tickets-1026755763127">event listing</a>, presenters will talk about how new generative AI approaches can transform real-world data 250 times faster than current methods.
IONQ Price Action: <a href="http://benzinga.com/quote/ionq">IonQ shares</a> closed Thursday up 0.54%. The stock was up another 0.54% in after-hours, trading at $9.30 at the time of publication, according to <a href="http://pro.benzinga.com">Benzinga Pro</a>.
Photo: Courtesy of IonQ.

After-Hours Center

IONQ

What's Going On With IonQ Stock Thursday?

Retail industry veteran Seth Golden recently warned that, according to a widely used oscillator Williams %R, the <a href="https://www.benzinga.com/topic/s-p-500">S&amp;P 500</a> has been overbought for an entire year.
Golden, a hedge fund consultant who previously worked for household names such as Target and now-defunct Bed Bath &amp; Beyond, pointed out that this is just the 23rd time in history that this has occurred.
Based on historical data he shared in a post on <a href="https://x.com/SethCL/status/1841808020705075700">X</a>, he pointed out that when this happened, it continued the same trend for the rest of the year — posting a fourth-quarter median return of 5.29%.
<a href="https://www.benzinga.com/11/04/1035270/pros-and-cons-of-williams-r-indicator">Williams %R</a>, often dubbed the Williams percent range, is a momentum indicator. It measures the overbought and oversold levels on a scale from 0 to 100. A reading above -20 is overbought and a reading below -80 is oversold.
Golden used a 28-month parameter, an industry standard for this indicator.
See Also: <a href="https://www.benzinga.com/general/travel/24/10/41172625/will-airlines-soar-or-stall-what-insider-trades-say-about-airline-industrys-future">Will Airlines Soar Or Stall? What Insider Trades Say About Industry&#8217;s Future</a>
Looking deeper into the list of overbought stocks brings an interesting mix of domestic and foreign catalysts.
Lockheed Martin's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LMT#NYSE">LMT</a>) presence on this list is unsurprising. The leading aerospace and defense manufacturer&#8217;s stock hit a fresh all-time high, reaching $609 and giving it a market cap of over $144B. The firm benefits from increased defense spending during <a href="https://www.benzinga.com/news/global/24/10/41126038/iran-attacks-israel-with-missiles-middle-east-tensions-escalates-s-p-500-stocks-bitcoin-fall-as-oil">escalating global conflicts</a> and with a <a href="https://www.benzinga.com/news/earnings/24/10/41164528/lockheed-wins-2-1b-contract-to-aid-trident-ii-d5-missile-program">new multi-billion U.S. Navy contract</a> it landed last Thursday. Despite a hefty $19.26B debt, the firm has the balance sheet to easily manage it, plus pay a reliable 2.1% dividend. Its Williams %R overbought score is currently -11.41.
Next on the list is Lowe's Companies Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LOW#NYSE">LOW</a>), a North Carolina-based retailer specializing in home improvement. It recently hit a new all-time high of $274.16. Along with other home improvement stocks, Lowe <a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/09/41008424/lowes-set-for-delayed-benefits-from-macro-demand-improvements-says-optimistic-analy">experienced a surge</a> following the FED's rate cut. Still, this strong performance is surprising, given the firm's revenue decline of nearly 10% year over year and dimmed future growth projections. Its Williams %R overbought score is currently -5.71.
Entergy Corp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ETR#NYSE">ETR</a>) has been a utility industry standout, delivering an almost 30% return year-to-date. Despite such numbers, the stock trades at a reasonable P/E ratio of 15.9x, below some of its peers like Exelon or FirstEnergy.
Entergy provides electric power to the southern U.S. states, benefiting from rapid energy growth in states such as Texas. Investors expect the company to scale with its target market, with a booming population and increased industrial activity prompting higher energy consumption. The stock's Williams %R overbought score currently stands at -7.41.
Read Next: <a href="https://www.benzinga.com/government/24/10/41172781/oil-prices-rally-biden-confirms-us-discussions-with-israel-about-striking-iran-facilities"> •&nbsp;Oil Prices Rally: Biden Confirms US &#8216;Discussions&#8217; With Israel About Striking Iran Facilities</a>
Photo: Shutterstock

Equities

Why S&P 500's Year-Long Overbought Signal Has This Expert Talking, Plus 3 Stocks To Watch

Restricted subsidiary Calumet Montana Refining, LLC (&quot;CMR&quot;) entered into a new agreement with Stonebriar in which CMR sold certain of its assets to Stonebriar for&nbsp;$150 million&nbsp;and leased back the same assets.

CLMT

Calumet Reveals Series Of Related Agreements With Stonebriar Commercial Finance

NewMarket Says William Skrobacz Is Stepping Down From His Role As Vice President And CFO, Effective December 31, 2024, As He Intends To Retire From Company In 2025; Timothy Fitzgerald Named As Successor

ConRes Test Equipment generates approximately&nbsp;$12 million&nbsp;in annual sales and is expected to be immediately accretive to DSG&#39;s adjusted EBITDA margins on a go-forward basis.
The transaction will be funded through DSG&#39;s existing cash and availability under its credit agreement and is expected to close in the&nbsp;fourth quarter&nbsp;of 2024, subject to customary closing conditions.
This acquisition is not expected to be material for financial reporting purposes to DSG&#39;s results.

DSGR

Distribution Solutions Group's TestEquity Agrees To Acquire ConRes Test Equipment; No Terms Disclosed

Under the agreement, TSMC will contract turnkey advanced packaging and test services from Amkor in their planned facility in Peoria, Arizona.
TSMC will leverage these services to support its customers, particularly those using TSMC&#39;s advanced wafer fabrication facilities in Phoenix.
The close collaboration and proximity of TSMC&#39;s front-end fab and Amkor&#39;s back-end facility will accelerate overall product cycle times.

AMKR

Amkor Technology, TSMC Sign MoU To Collaborate And Bring Advanced Packaging And Test Capabilities To Arizona

5 analysts have shared their evaluations of Liberty Energy (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LBRT#NYSE">LBRT</a>) during the recent three months, expressing a mix of bullish and bearish perspectives.
The following table summarizes their recent ratings, shedding light on the changing sentiments within the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th style="text-align: right;">Bullish</th>
<th style="text-align: right;">Somewhat Bullish</th>
<th style="text-align: right;">Indifferent</th>
<th style="text-align: right;">Somewhat Bearish</th>
<th style="text-align: right;">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
</tbody>
</table>
Analysts have recently evaluated Liberty Energy and provided 12-month price targets. The average target is $23.6, accompanied by a high estimate of $26.00 and a low estimate of $20.00. Experiencing a 7.81% decline, the current average is now lower than the previous average price target of $25.60. 
<img src="https://www.benzinga.com/files/images/story/2024/1727989298_0.png" alt="price target chart" />
<h2>Deciphering Analyst Ratings: An In-Depth Analysis</h2>
An in-depth analysis of recent analyst actions unveils how financial experts perceive Liberty Energy. The following summary outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Scott Gruber</td>
<td>Citigroup</td>
<td>Lowers</td>
<td>Buy</td>
<td>$25.00</td>
<td>$28.00</td>
</tr>
<tr>
<td>Derek Podhaizer</td>
<td>Barclays</td>
<td>Lowers</td>
<td>Overweight</td>
<td>$26.00</td>
<td>$27.00</td>
</tr>
<tr>
<td>Marc Bianchi</td>
<td>TD Cowen</td>
<td>Lowers</td>
<td>Hold</td>
<td>$20.00</td>
<td>$21.00</td>
</tr>
<tr>
<td>Chase Mulvehill</td>
<td>B of A Securities</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$22.00</td>
<td>$24.00</td>
</tr>
<tr>
<td>Luke Lemoine</td>
<td>Piper Sandler</td>
<td>Lowers</td>
<td>Overweight</td>
<td>$25.00</td>
<td>$28.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: In response to dynamic market conditions and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their reaction to recent developments related to Liberty Energy. This insight gives a snapshot of analysts' perspectives on the current state of the company.</li>
<li>Rating: Offering a comprehensive view, analysts assess stocks qualitatively, spanning from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of Liberty Energy compared to the broader market.</li>
<li>Price Targets: Analysts gauge the dynamics of price targets, providing estimates for the future value of Liberty Energy's stock. This comparison reveals trends in analysts' expectations over time.</li>
</ul>
Understanding these analyst evaluations alongside key financial indicators can offer valuable insights into Liberty Energy's market standing. Stay informed and make well-considered decisions with our Ratings Table.
<a href="https://www.benzinga.com/quote/LBRT/analyst-ratings?utm_source=Benzinga Insights">Stay up to date on Liberty Energy analyst ratings.</a>
<h2>Delving into Liberty Energy's Background</h2>
Liberty Energy is an oilfield services company that provides hydraulic fracturing services—mainly pressure pumping—in major basins throughout North America. Its 2020 acquisition of Schlumberger's OneStim business segment made Liberty one of the largest pressure pumpers in North America. It also added wireline operations, two Permian frac sand mines, and an expanded technological portfolio.
<h3>Breaking Down Liberty Energy's Financial Performance</h3>
Market Capitalization Analysis: Positioned below industry benchmarks, the company's market capitalization faces constraints in size. This could be influenced by factors such as growth expectations or operational capacity.
Revenue Growth: Liberty Energy's revenue growth over a period of 3 months has faced challenges. As of 30 June, 2024, the company experienced a revenue decline of approximately -2.94%. This indicates a decrease in the company's top-line earnings. As compared to competitors, the company encountered difficulties, with a growth rate lower than the average among peers in the Energy sector.
Net Margin: Liberty Energy's financial strength is reflected in its exceptional net margin, which exceeds industry averages. With a remarkable net margin of 9.35%, the company showcases strong profitability and effective cost management.
Return on Equity (ROE): Liberty Energy's financial strength is reflected in its exceptional ROE, which exceeds industry averages. With a remarkable ROE of 5.67%, the company showcases efficient use of equity capital and strong financial health.
Return on Assets (ROA): Liberty Energy's ROA surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive 3.42% ROA, the company effectively utilizes its assets for optimal returns.
Debt Management: Liberty Energy's debt-to-equity ratio is below the industry average at 0.24, reflecting a lower dependency on debt financing and a more conservative financial approach.
<h2>What Are Analyst Ratings?</h2>
Ratings come from analysts, or specialists within banking and financial systems that report for specific stocks or defined sectors (typically once per quarter for each stock). Analysts usually derive their information from company conference calls and meetings, financial statements, and conversations with important insiders to reach their decisions.
Some analysts publish their predictions for metrics such as growth estimates, earnings, and revenue to provide additional guidance with their ratings. When using analyst ratings, it is important to keep in mind that stock and sector analysts are also human and are only offering their opinions to investors.
Breaking: Wall Street's Next Big Mover
Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. <a href="https://www.benzinga.com/premium/ideas/turning-point-trader-checkout-2/?t=Tu1tu3arja3be22tu36&amp;utm_source=benzinga-insights">Click here for urgent details</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

LBRT

Forecasting The Future: 5 Analyst Projections For Liberty Energy

Travere slips after pausing late-stage trial's enrollments

TD Cowen analyst Tyler Van Buren maintained a Buy rating on Travere Therapeutics (TVTX – Research Report) today and set a price target of $15.00. T...

TD Cowen Sticks to Its Buy Rating for Travere Therapeutics (TVTX)

There's a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Adverum Biotechnologies (ADVM – Research Report), Bi...

Analysts Offer Insights on Healthcare Companies: Adverum Biotechnologies (ADVM), Biomea Fusion (BMEA) and Travere Therapeutics (TVTX)

There's a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on DENTSPLY SIRONA (XRAY – Research Report) and Travere...

Analysts Offer Insights on Healthcare Companies: DENTSPLY SIRONA (XRAY) and Travere Therapeutics (TVTX)

There's a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Curis (CRIS – Research Report), Scholar Rock Holding...

Analysts Offer Insights on Healthcare Companies: Curis (CRIS), Scholar Rock Holding (SRRK) and Travere Therapeutics (TVTX)

Analysts have been eager to weigh in on the Healthcare sector with new ratings on Travere Therapeutics (TVTX – Research Report) and Elanco Animal H...

Analysts Offer Insights on Healthcare Companies: Travere Therapeutics (TVTX) and Elanco Animal Health (ELAN)

Analysts have been eager to weigh in on the Healthcare sector with new ratings on Lexicon Pharmaceuticals (LXRX – Research Report) and Travere Ther...

Analysts Offer Insights on Healthcare Companies: Lexicon Pharmaceuticals (LXRX) and Travere Therapeutics (TVTX)

Analyst Joseph Schwartz from Leerink Partners maintained a Buy rating on Travere Therapeutics (TVTX – Research Report) and keeping the price target...

Outperform Rating Reaffirmed for Travere Therapeutics Amid Manufacturing Setback

Travere Therapeutics Faces Challenges But Holds Promise With Filspari Beyond IgAN

Analyst Edward Nash from Canaccord Genuity maintained a Buy rating on Travere Therapeutics (TVTX – Research Report) and keeping the price target at...

Strong Buy Rating for Travere Therapeutics Backed by Filspari's Market Potential and Full FDA Approval

ADVM

BMEA

CRIS

ELAN

LXRX

SRRK

XRAY

Press Releases

Ligand Reports Second Quarter 2024 Financial Results

Travere Therapeutics to Present at Upcoming Investor Conferences

Health Care

Travere Therapeutics to Present Abstracts at the Society for the Study of Inborn Errors of Metabolism Annual Symposium 2024

Travere Therapeutics Announces Full FDA Approval of FILSPARI® (sparsentan), the Only Non-Immunosuppressive Treatment that Significantly Slows Kidney Function Decline in IgA Nephropathy

Ligand Partner Travere Therapeutics Receives Full FDA Approval for FILSPARI® (sparsentan), the Only Non-Immunosuppressive Treatment that Significantly Slows Kidney Function Decline in IgA Nephropathy

Travere Therapeutics to Present at the 2024 Cantor Global Healthcare Conference

Travere Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Travere Therapeutics Announces Voluntary Pause of Enrollment in the Phase 3 HARMONY Study of Pegtibatinase Related to Commercial Manufacturing Scale-Up

TVTX INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces an Investigation into Travere Therapeutics, Inc. and Encourages Investors to Contact the Firm

AGEN

AMGN

CASI

LGND

MRNS

OVID

PIRS

VKTX

VRNA

AnaptysBio

Applied Therapeutics, Inc. - Common Stock

Applied Therapeutics

Arcutis Biotherapeutics, Inc. - Common stock

Arcutis Biotherapeutics

Autolus Therapeutics plc - American Depositary Shares

Autolus Therapeutics

Bicara Therapeutics

Perspective Therapeutics, Inc. Common Stock

Perspective Therapeutics

Cullinan Therapeutics, Inc. - Common Stock

Cullinan Therapeutics

Cogent Biosciences

Day One Biopharmaceuticals, Inc. - Common Stock

Day One Biopharmaceutical

Gyre Therapeutics

Immatics

Mesoblast Limited - American Depositary Shares

Mesoblast

Oruka Therapeutics

Praxis Precision Medicines, Inc. - Common Stock

Praxis Precision Medicine

Prothena Corporation plc - Ordinary Shares

Prothena Corp

Arcus Biosciences

Relay Therapeutics

Sana Biotechnology

Silence Therapeutics Plc - American Depository Share

Silence Therapeutics

ARS Pharmaceuticals

Spyre Therapeutics

Tyra Biosciences

Vir Biotechnology

Xencor

Zymeworks

Barclays

Canaccord Genuity

Citigroup

Guggenheim

B of A Securities

금요일 오전 (현지 시간 기준) 미국 주식 선물 거래가 혼조세를 보이고 있는 가운데 오늘 투자자들의 관심을 끌 수 있는 주식은 다음과 같다:
1. 코스트코 홀세일(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/COST#NASDAQ">COST</a>)는 4분기 긍정적인 실적을 발표했지만, 매출은 예상에 미치지 못했다. 이 회사는 <a href="https://www.benzinga.com/news/earnings/24/09/41056967/costco-q4-earnings-revenue-miss-eps-beat-comps-climb-5-4-shares-slide">분기 매출이 796.97억 달러</a>로, 컨센서스 추정치인 799.73억 달러를 밑돌았다고 보고했다. 이 회원제 소매업체는 분기당 주당 순이익이 5.29달러로, 애널리스트 추정치인 5.08달러를 초과했다고 보고했다. 코스트코의 주식은 시간외 거래에서 1.4% 하락한 888.62달러에 거래되었다.
2. 무빙 이미지 테크놀로지스(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MITQ#NYSE">MITQ</a>)는 4분기 재무 및 운영 실적을 발표할 예정이다. 무빙 이미지 테크놀로지스의 주식은 시간외 거래에서 5% 상승하여 0.5985달러에 거래되었다.
3. 스콜라스틱 코퍼레이션(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SCHL#NASDAQ">SCHL</a>)은 목요일 시장 마감 후 1분기 실적이 예상보다 좋다고 발표했다. 스콜라스틱은 주당 손실이 2.13달러로 예상 손실 2.48달러보다 좋았다고 보고했다. 이 회사는 분기 매출이 2억 3,720만 달러로 애널리스트 컨센서스 추정치인 2억 3,348만 달러를 초과했다고 보고했다. 스콜라스틱의 주식은 시간외 거래에서 6.5% 상승하여 32.13달러에 거래되었다.
프리마켓 보도를 확인하려면 <a href="https://www.benzinga.com/premarket/">여기를 클릭하세요</a>.
4. 이엔비베노 메디컬 코퍼레이션(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVNO#NASDAQ">NVNO</a>) 공모를 제안했습니다. 이 회사의 주식은 시간외 거래에서 15.6% 하락하여 3.80달러에 거래되었다.
5. 트래비어 테라퓨틱스(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TVTX#NASDAQ">TVTX</a>)는 페그티바티나제(Pegtibatinase)에 대한 3상 하모니(HARMONY) 연구 등록을 자발적으로 중단한다고 발표했다. 트래비어 테라퓨틱스의 주가는 시간외 거래에서 5.3% 하락한 14.24달러를 기록했다.
이것도 확인하세요:
<ul>
<li><a href="https://www.benzinga.com/markets/24/09/41054730/top-3-tech-stocks-that-are-ticking-portfolio-bombs">포트폴리오 폭탄이 될 수 있는 상위 3개 기술 주식</a></li>
</ul>
사진 출처: Flickr
Benzinga Pro의 독점 뉴스 및 도구로 더 많은 승리를 거두세요 
독점 속보 및 스캐너와 같은 Benzinga Pro의 강력한 도구 세트로 다른 트레이더보다 우위를 점하세요. 
<a href="https://www.benzinga.com/pro/register?t=be2bewe5mibe3bz3&amp;utm_source=bz-kor" target="_blank" rel="noreferrer noopener">여기를 클릭</a>하여 14일 무료 체험을 시작하세요.

Comments

Travere Therapeutics

뉴스

에 대한 최신 뉴스 Travere Therapeutics (NASDAQ:TVTX) 주식

금요일, 9월 27, 2024

사람들이 또한 지켜본다

뉴스

파트너 / 기고자

벤징가 글로벌